MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The feasibility and efficacy of speech therapy via video call in patients with Parkinson’s disease: a preliminary study

HJ. Chang, J. Kim, KA. Woo, JY. Joo, S. Kim, S. Lee, B. Jin, HY. Jeon, B. Jeon, HJ. Kim (Daejeon, Republic of Korea)

Meeting: 2023 International Congress

Abstract Number: 36

Keywords: Parkinson’s

Category: Parkinson’s Disease: Clinical Trials

Objective: To evaluate the feasibility and efficacy of video call-based speech therapy for patients with Parkinson’s disease (PD) with speech problems.

Background: PD patients commonly have speech problems, negatively affecting their quality of life and burden their caregivers. Intensive speech treatments that increase vocal effort and loudness are effective in managing speech problems in PD patients, but frequent visits are required, which can be difficult for patients due to distance constraints and transportation difficulties. Online speech therapy via video call is explored as an alternative for PD patients.

Method: A prospective, non-randomized, open-label comparative study was conducted between July and September 2021. PD patients with speech problems were recruited from Seoul National University Hospital divided into two groups based on their ability to visit the hospital frequently: online speech therapy via video call and in-person therapy. Patients received 12 sessions of 50-minute speech therapy focused on respiration and phonation. Acoustic assessments, auditory-perceptual assessment, and voice handicap index (K-VHI10) were evaluated at baseline, post-therapy, and follow-up evaluation.

Results: Eleven patients were enrolled, one from the online group dropped out, for ten completed the therapy (five in each group) without missing a session. The mean age was 65.6 ± 8.2 years old, and the mean disease duration was 7.5 ± 8.0 years. The modified Hoehn and Yahr scale ranged from 1 to 3 (mean 2.05 ± 0.69). At the post-therapy evaluation, any acoustic measurements did not differ significantly between the two groups. In the follow-up evaluation, the effect of therapy remained the same. Additionally, both group showed decrease in jitter, and an increase in the intensity of vowel of /a/ and reading. There was no difference in auditory perceptual measurement between the two groups, and both showed improvement in overall loudness after therapy. K-VHI10 decreased significantly from baseline to post-therapy and further decreased at follow-up in both groups, with no significant difference between two groups.

Conclusion: This study showed that the online speech therapy conducted via video call is feasible and as effective as the in-person therapy for PD patients with speech problems making it a viable alternative for PD patients.

To cite this abstract in AMA style:

HJ. Chang, J. Kim, KA. Woo, JY. Joo, S. Kim, S. Lee, B. Jin, HY. Jeon, B. Jeon, HJ. Kim. The feasibility and efficacy of speech therapy via video call in patients with Parkinson’s disease: a preliminary study [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/the-feasibility-and-efficacy-of-speech-therapy-via-video-call-in-patients-with-parkinsons-disease-a-preliminary-study/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-feasibility-and-efficacy-of-speech-therapy-via-video-call-in-patients-with-parkinsons-disease-a-preliminary-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley